Healthcare Analytical Testing Services Market
Report Code
AST 4341
Published in
Sep, 2026, By MarketsandMarkets™
Healthcare Analytical Testing Services Market by Test Type (Cell-based, Bioanalytical, Raw Material, Microbial, Batch-Release, Genomic, Method Development & Validation, Endotoxin), End User (Pharma, Biopharma, Medical Device, Clinic) - Global forecast to 2031
$7,750M
MARKET SIZE, 2026
$12,470M
MARKET SIZE, 2031
10.0%
CAGR (2026-2031)
2026-2031
FORECAST PERIOD
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global healthcare analytical testing services market is projected to grow from USD 7,750 million in 2026 to USD 12,470 million by 2031, at a CAGR of 10.0% during the forecast period. The market was valued at USD 7,350 million in 2025. Market growth is supported by increasing demand for GMP-compliant drug substance (DS) and drug product (DP) analytical testing across all phases of drug development. Testing providers are expanding capabilities in analytical method development and validation, stability testing, release and quality control testing, physicochemical characterization, mass spectrometry, potency bioassays, molecular biology, microbiology, impurity identification, and infectivity testing. The growing development of small molecules, biologics, inhaled products, cell and gene therapies, and drug-device combination products, combined with the need to meet global regulatory requirements, is further driving demand for specialized analytical testing services.
KEY TAKEAWAYS
-
MARKET SNAPSHOT:
Base Year Market Size (2025): USD 7,350 Million
Current Market Size (2026): USD 7,750 Million
Forecast Market Size (2031): USD 12,470 Million
CAGR (2026–2031): 10.0% -
SEGMENT LEADERSHIP:
Regional Leader: North America accounted for the largest market share of 45% in 2025.
Service Leader: Bioanalytical testing services accounted for the largest market share of 37%.
End User Leader: Pharmaceutical companies accounted for the largest market share of 32% in 2025. -
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
Eurofins Scientific SE, Intertek Group plc, ICON plc, IQVIA Inc., and Labcorp Holdings Inc. are among the leading healthcare analytical testing services providers. These companies compete through broad analytical testing capabilities, regulatory expertise, global laboratory networks, and specialized services across pharmaceutical and biopharmaceutical development.
Syneos Health, Parexel International, LGC Limited, Celerion, Alcami Corporation, Samsung Biologics, and Curia Global, Inc. are among the emerging players, focusing on specialized analytical testing, bioanalytical services, GMP testing, biologics, and other niche laboratory capabilities.
Market growth is supported by increasing demand for GMP-compliant drug substance (DS) and drug product (DP) analytical testing across all phases of drug development. Testing providers are expanding capabilities in analytical method development and validation, stability testing, release and quality control testing, physicochemical characterization, mass spectrometry, potency bioassays, molecular biology, microbiology, impurity identification, and infectivity testing. The growing development of small molecules, biologics, inhaled products, cell and gene therapies, and drug-device combination products, combined with the need to meet global regulatory requirements, is further driving demand for specialized analytical testing services.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The healthcare analytical testing services market is increasingly shaped by the evolving requirements of pharmaceutical and biopharmaceutical companies. Pharmaceutical companies are prioritizing faster analytical testing, GMP-compliant quality control and release testing, and robust stability, impurity, and method validation capabilities, while biopharmaceutical companies are seeking advanced characterization of complex biologics and therapies, specialized bioanalytical and potency assays, and compliance with stringent regulatory requirements. These imperatives are driving faster time to market, higher testing accuracy and data reliability, improved regulatory compliance, greater testing efficiency and faster turnaround, and more scalable and specialized analytical workflows.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Stringent regulatory guidelines
-
Growing focus on analytical testing of biologics & biosimilars
RESTRAINTS
Impact
Level
Level
-
Increasing pressure on market players due to rising costs and market competition
-
High equipment and operational costs
OPPORTUNITIES
Impact
Level
Level
-
Adoption of new techniques and technologies
-
Growing focus on emerging economies
CHALLENGES
Impact
Level
Level
-
Shortage of skilled professionals
-
Specific requirements for innovative formulations and medical devices
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Stringent regulatory guidelines
Stringent regulatory requirements from agencies such as the FDA and EMA are driving demand for reliable, validated, and compliant analytical testing services. Pharmaceutical and biopharmaceutical companies increasingly require testing support to meet quality, safety, and regulatory requirements throughout drug development and manufacturing.
Restraint: Increasing pressure on market players due to rising costs and market competition
The healthcare analytical testing services market is highly competitive, with increasing demand for specialized testing services and growing competition from contract development and manufacturing organizations (CDMOs) and local testing providers. Rising equipment, operational, and technology costs can place pressure on service providers, particularly in emerging markets.
Opportunity: Adoption of new techniques and technologies
The adoption of advanced analytical techniques and technologies creates opportunities for testing service providers to improve testing accuracy, efficiency, and turnaround times. Emerging technologies and advanced analytical platforms can support increasingly complex testing requirements across pharmaceutical and biopharmaceutical development.
Challenge: Shortage of skilled professionals
The increasing complexity of analytical testing requires professionals with specialized expertise in analytical methods, instrumentation, data interpretation, and regulatory requirements. A shortage of skilled personnel can create challenges for testing providers in expanding capabilities and maintaining efficient service delivery.
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides comprehensive testing across pharmaceutical, biopharmaceutical, food, environmental, cosmetic, genomics, and clinical applications, using analytical chemistry and biotechnology capabilities. Its pharmaceutical services support drug development, quality and safety testing, and regulatory requirements. | Delivers accurate and timely analytical results, broad testing capabilities, regulatory support, and access to advanced technologies and laboratory expertise. |
 |
Supports pharmaceutical and biotechnology companies across the product development and commercialization lifecycle through full-service, blended, and functional service models, with expertise across clinical and scientific operations and multiple therapeutic areas. | Helps accelerate development timelines, improve R&D efficiency, reduce costs, and provide flexible solutions through specialized operational and therapeutic expertise. |
 |
Provides GLP, GCP, and GMP pharmaceutical laboratory services covering CMC programs, method development and validation, analytical testing, stability studies, extractables and leachables, impurity and elemental analysis, quality control, batch release, bioanalysis, and biopharmaceutical characterization. | Supports regulatory compliance, product quality, faster development, and reliable testing through flexible laboratory services and specialized expertise in complex medicines, biologics, and drug-delivery systems. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The healthcare analytical testing services market ecosystem comprises analytical testing service providers, pharmaceutical companies, biopharmaceutical companies, medical device companies, hospitals & clinics, forensic labs, cosmetic & nutraceutical companies, and other end users, along with relevant government and regulatory bodies. Key analytical testing service providers include Eurofins Scientific, Intertek Group, ICON, IQVIA, Labcorp, Thermo Fisher Scientific, SGS, Element Materials Technology, Pace Analytical Services, and Merck KGaA. These service providers offer analytical testing and laboratory solutions across areas such as bioanalytical testing, physical characterization, method development and validation, raw material testing, batch-release testing, stability testing, microbial testing, environmental monitoring, and genomic testing. Pharmaceutical, biopharmaceutical, medical device, healthcare, forensic, cosmetic, and nutraceutical organizations generate demand for analytical testing services to support product development, quality control, safety, regulatory compliance, and commercialization, while government and regulatory bodies establish standards and guidelines governing testing quality, safety, and compliance.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Healthcare Analytical Testing Services Market, By Region
North America accounted for the largest share of the healthcare analytical testing services market in 2025, supported by strong pharmaceutical and biopharmaceutical R&D, advanced laboratory infrastructure, and stringent regulatory requirements.
Healthcare Analytical Testing Services Market, By Type
Bioanalytical testing services accounted for the largest share of the market in 2025, driven by increasing demand for pharmacokinetic and toxicokinetic testing, immunogenicity and neutralizing antibody testing, biomarker testing, and bioassays across pharmaceutical and biopharmaceutical development.
Healthcare Analytical Testing Services Market, By End User
Pharmaceutical companies accounted for the largest share of the market in 2025, driven by increasing demand for GMP-compliant analytical testing across drug development and manufacturing, including method development and validation, stability testing, quality control, batch-release testing, and impurity analysis.
REGION
Asia Pacific is expected to register the highest CAGR in the healthcare analytical testing services market during the forecast period.
Asia Pacific is expected to register the highest CAGR in the healthcare analytical testing services market, supported by expanding pharmaceutical and biopharmaceutical R&D, increasing investments in healthcare and laboratory infrastructure, and growing demand for GMP-compliant analytical testing. Rising drug development activities and the increasing need for bioanalytical, stability, microbial, and method development and validation services across China, India, Japan, and South Korea are expected to accelerate market growth in the region.
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION MATRIX
Company evaluation in the healthcare analytical testing services market indicates a competitive landscape led by established providers with broad service portfolios and strong market presence. Eurofins Scientific SE is positioned as a Star, reflecting its strong product footprint and market share/rank, while Pace Analytical Services is positioned as an Emerging Leader with growing capabilities and market presence. Other companies are distributed across the Participants and Pervasive Players categories, indicating varying levels of service breadth and market strength across the competitive landscape.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 7,350 million |
| Market Size in 2026 (Value) | USD 7,750 million |
| Market Forecast in 2031 (value) | USD 12,470 million |
| CAGR | 10% from 2026 to 2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD million) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Pharmaceutical & Biopharmaceutical Companies | Competitive benchmarking of key healthcare analytical testing providers across bioanalytical testing, physical characterization, method development & validation, raw material testing, batch-release testing, stability testing, microbial testing, environmental monitoring, and genomic testing. | Insights into GMP-compliant testing capabilities, regulatory requirements, specialized analytical services, and opportunities across drug development and manufacturing. |
| Medical Device Companies | Assessment of analytical testing requirements across physical characterization, extractables & leachables, microbial testing, raw material testing, and other specialized testing services. | Identification of testing needs supporting product quality, safety, regulatory compliance, and faster product development. |
| Research & Academic Institutes | Analysis of demand for analytical testing across pharmaceutical and biopharmaceutical research, including bioanalytical testing, physical characterization, method development, and genomic testing. | Identification of high-demand analytical testing areas and insights into advanced, accurate, and specialized laboratory testing requirements. |
RECENT DEVELOPMENTS
- April 2025 : Eurofins announced the successful closing of its acquisition of SYNLAB’s clinical diagnostics operations in Spain, expanding its clinical diagnostics network and strengthening its capabilities in genetics and anatomical pathology testing.
- May 2025 : Intertek expanded its GMP pharmaceutical services laboratory in Melbourn, near Cambridge, UK, by adding 6,000 square feet of laboratory and office space, enhancing its capabilities in inhaled biologics through advanced mass spectrometry, particle characterization, bioassays, and cell culture.
- January 2026 : Labcorp announced a new 500,000+ sq. ft. Central Laboratory Services facility in Brownsburg, Indiana, including CLS laboratories, kit production, bioanalytical services, and advanced laboratory infrastructure. Construction is planned to begin in H2 2026.
- February 2026 : On February 25, 2026, IQVIA announced an agreement to acquire five drug discovery sites and related assets from Charles River Laboratories, including in vitro New Approach Methodologies (NAMs) and a small molecule AI platform.The acquisition will expand IQVIA’s end-to-end drug discovery capabilities, covering target identification through early safety assessment and supporting non-animal research methods.
- April 2026 : On April 2, 2026, Pace Life Sciences announced the expansion of its microbial limits testing laboratory in Lebanon, New Jersey, increasing testing capacity, efficiency, and reliability. The expansion strengthens its analytical testing services, supporting pharmaceutical and biopharmaceutical programs from early development through commercialization.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
15
2
EXECUTIVE SUMMARY
3
PREMIUM INSIGHTS
4
MARKET OVERVIEW
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
4.1
MARKET DYNAMICS
4.1.1
DRIVERS
4.1.2
RESTRAINTS
4.1.3
OPPORTUNITIES
4.1.4
CHALLENGES
4.2
UNMET NEEDS AND WHITE SPACES
4.3
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
BARGAINING POWER OF SUPPLIERS
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
THREAT OF SUBSTITUTES
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC INDICATORS
5.2.1
INTRODUCTION
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES INDUSTRY
5.3
VALUE CHAIN ANALYSIS
5.4
SUPPLY CHAIN ANALYSIS
5.5
ECOSYSTEM MARKET MAP
5.6
PRICING ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND OF KEY PRODUCT TYPE, BY KEY PLAYERS (2023–2025)
5.6.2
AVERAGE SELLING PRICE TREND OF PRODUCT TYPE, BY REGION (2023–2025)
5.7
TRADE ANALYSIS
5.7.1
EXPORT SCENARIO
5.7.2
IMPORT SCENARIO
5.8
KEY CONFERENCES & EVENTS IN 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.11
CASE STUDY ANALYSIS
5.12
IMPACT OF 2025 US TARIFF: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
5.12.1
INTRODUCTION
5.12.2
KEY TARIFF RATES
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUNTRY/REGION
5.12.4.1
US
5.12.4.2
EUROPE
5.12.4.3
ASIA PACIFIC
5.12.5
IMPACT OF END USE INDUSTRIES
6
STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.4
PATENT ANALYSIS
6.5
IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
6.5.1
TOP USE CASES AND MARKET POTENTIAL
6.5.2
BEST PRACTICES IN THE HEALTHCARE ANALYTICAL TESTING SERVICES INDUSTRY
6.5.3
CASE STUDIES OF AI IMPLEMENTATION IN THE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
6.5.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.5.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
6.6
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7
REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2
REGULATORY SCENARIO, BY COUNTRY
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET DATA, BY TYPE (MARKET SIZE & FORECAST TO 2031-IN VALUE, USD MILLION)
COMPARATIVE ASSESSMENT OF PRODUCT-CATEGORY DEMAND, PURCHASING PATTERNS, TECHNOLOGY ADOPTION, AND MARKET POTENTIAL ACROSS REGIONS AND COUNTRIES
9.1
INTRODUCTION
9.2
BIOANALYTICAL TESTING SERVICES
9.2.1
PHARMACOKINETIC & TOXICOKINETIC TESTING
9.2.2
IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING
9.2.3
BIOMARKER TESTING
9.2.4
BIOASSAY TESTING
9.2.5
OTHER BIOANALYTICAL TESTING SERVICES
9.3
PHYSICAL CHARACTERIZATION SERVICES
9.3.1
LASER PARTICLE SIZE ANALYSIS
9.3.2
THERMAL ANALYSIS
9.3.3
OPTICAL CHARACTERIZATION
9.3.4
SURFACE AREA ANALYSIS
9.3.5
OTHER PHYSICAL CHARACTERIZATION SERVICES
9.4
METHOD DEVELOPMENT & VALIDATION SERVICES
9.4.1
EXTRACTABLE & LEACHABLE METHOD DEVELOPMENT & VALIDATION
9.4.2
PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION
9.4.3
STABILITY-INDICATING METHOD VALIDATION
9.4.4
CLEANING VALIDATION & METHOD DEVELOPMENT
9.4.5
ANALYTICAL STANDARD CHARACTERIZATION
9.4.6
TECHNICAL CONSULTING
9.4.7
OTHER METHOD DEVELOPMENT & VALIDATION SERVICES
9.5
RAW MATERIAL TESTING SERVICES
9.5.1
COMPLETE COMPENDIAL TESTING
9.5.2
HEAVY METAL TESTING
9.5.3
CONTAINER TESTING
9.5.4
WATER CONTENT ANALYSIS
9.5.5
OTHER RAW MATERIAL TESTING SERVICES
9.6
BATCH-RELEASE TESTING SERVICES
9.6.1
DISSOLUTION TESTING
9.6.2
ELEMENTAL IMPURITY TESTING
9.6.3
DISINTEGRATION TESTING
9.6.4
HARDNESS TESTING
9.6.5
FRIABILITY TESTING
9.6.6
OTHER BATCH-RELEASE TESTING SERVICES
9.7
STABILITY TESTING SERVICES
9.7.1
DRUG SUBSTANCE STABILITY TESTING
9.7.2
FORMULATION EVALUATION STABILITY TESTING
9.7.3
ACCELERATED STABILITY TESTING
9.7.4
PHOTOSTABILITY TESTING
9.7.5
FORCED DEGRADATION TESTING
9.7.6
OTHER STABILITY TESTING SERVICES
9.8
MICROBIAL TESTING SERVICES
9.8.1
MICROBIAL LIMIT TESTING
9.8.2
VIROLOGY TESTING
9.8.3
STERILITY TESTING
9.8.4
ENDOTOXIN TESTING
9.8.5
PRESERVATIVE EFFICACY TESTING
9.8.6
OTHER MICROBIAL TESTING SERVICES
9.9
ENVIRONMENTAL MONITORING SERVICES
9.8.1
AIR TESTING
9.8.2
WASTEWATER/ETP TESTING
9.8.3
OTHER ENVIRONMENTAL MONITORING TESTING
9.9
GENOMIC TESTING SERVICES
9.10
OTHER ANALYTICAL TESTING SERVICES
10
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
END-USER-SPECIFIC PURCHASING BEHAVIOR, ADOPTION FACTORS, TESTING VOLUMES, BUDGET PRIORITIES, AND MARKET POTENTIAL
10.1
PHARMACEUTICAL COMPANIES
10.2
BIOPHARMACEUTICAL COMPANIES
10.3
MEDICAL DEVICE COMPANIES
10.4
HOSPITALS & CLINICS
10.5
FORENSIC LABS
10.6
COSMETIC & NUTRACEUTICAL COMPANIES
10.7
OTHER END USERS
11
HEALTHCARE ANALYTICAL TESTING SERVICES MARKET DATA, BY REGION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
ASSESSING GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY REGIONS AND COUNTRIES
11.1
INTRODUCTION
11.2
NORTH AMERICA
11.2.1
US
11.2.2
CANADA
11.3
EUROPE
11.3.1
GERMANY
11.3.2
UK
11.3.3
FRANCE
11.3.4
ITALY
11.3.5
SPAIN
11.3.6
REST OF EUROPE
11.4
ASIA-PACIFIC
11.4.1
CHINA
11.4.2
JAPAN
11.4.3
INDIA
11.4.4
SOUTH KOREA
11.4.5
AUSTRALIA
11.4.6
REST OF ASIA PACIFIC
11.5
LATIN AMERICA
11.5.1
BRAZIL
11.5.2
MEXICO
11.5.3
REST OF LATIN AMERICA
11.6
MIDDLE EAST & AFRICA
11.6.1
GCC COUNTRIES
11.6.2
REST OF MIDDLE EAST & AFRICA
12
COMPETITIVE LANDSCAPE
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
12.1
INTRODUCTION
12.2
KEY PLAYER STRATEGIES/RIGHT TO WIN (2022–2026)
12.3
REVENUE ANALYSIS (2021–2025)
12.4
MARKET SHARE ANALYSIS OF KEY PLAYERS,
12.5
COMPANY EVALUATION MATRIX: KEY PLAYERS,
12.5.1
STARS
12.5.2
EMERGING LEADERS
12.5.3
PERVASIVE PLAYERS
12.5.4
PARTICIPANTS
12.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
12.5.5.1
COMPANY FOOTPRINT
12.5.5.2
REGION FOOTPRINT
12.5.5.3
PRODUCT FOOTPRINT
12.5.5.4
MATERIAL FOOTPRINT
12.5.5.6
END USER FOOTPRINT
12.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
12.6.1
PROGRESSIVE COMPANIES
12.6.2
RESPONSIVE COMPANIES
12.6.3
DYNAMIC COMPANIES
12.6.4
STARTING BLOCKS
12.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
12.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
12.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
12.7
COMPETITIVE SCENARIO AND TRENDS (2021–2025)
12.7.1
NEW PRODUCT LAUNCHES & APPROVALS
12.7.2
DEALS
12.7.3
OTHER DEVELOPMENTS
12.8
BRAND/PRODUCT COMPARATIVE ANALYSIS PRODUCT COMPARISON
12.9
COMPANY VALUATION AND FINANCIAL METRICS
13
COMPANY PROFILES
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET LANDSCAPE
13.1
KEY PLAYERS
13.1.1
EUROFINS SCIENTIFIC
13.1.2
LABORATORY CORPORATION OF AMERICA HOLDINGS
13.1.3
WUXI APPTECH
13.1.4
CHARLES RIVER LABORATORIES
13.1.5
SGS S.A.
13.1.6
THERMO FISHER SCIENTIFIC INC
13.1.7
MEDPACE, INC.
13.1.8
SARTORIUS AG.
13.1.9
INTERTEK GROUP PLC
13.1.10
MERCK KGAA
13.1.11
SOURCE BIOSCIENCE
13.1.12
ICON PLC
13.1.13
ALS
13.1.14
FRONTAGE LABORATORIES, INC.
13.1.15
STERIS
13.1.16
IQVIA INC.
13.1.17
ELEMENT MATERIALS TECHNOLOGY
13.1.18
PACE ANALYTICAL SERVICES
13.1.19
ALMAC GROUP
13.1.20
PHARMARON
13.2
EMERGING PLAYERS
13.2.1
SYNEOS HEALTH
13.2.2
PAREXEL INTERNATIONAL (MA) CORPORATION
13.2.3
LGC LIMITED
13.2.4
CELERION
13.2.5
BIOAGILYTIX LABS
13.2.6
ALCAMI CORPORATION
13.2.7
ARDENA
13.2.8
LABCORP DRUG DEVELOPMENT (FORMERLY COVANCE)
13.2.9
ARAGEN LIFE SCIENCES
13.2.10
AVANCE BIOSCIENCES
14
RESEARCH METHODOLOGY
14.1
RESEARCH DATA SOURCES
14.1.1
SECONDARY RESEARCH
14.1.2
PRIMARY RESEARCH
14.2
MARKET SIZE ESTIMATION METHODOLOGY
14.2.1
REVENUE-MAPPING BASED MARKET ESTIMATION
14.2.2
END-USER BASED MARKET ESTIMATION
14.3
MARKET FORECASTING APPROACH
14.4
MARKET BREAKDOWN AND DATA TRIANGULATION
14.5
RESEARCH ASSUMPTIONS
14.6
RESEARCH LIMITATIONS
14.6.1
SCOPE-RELATED LIMITATIONS
14.6.2
METHODOLOGY-RELATED LIMITATIONS
14.7
RISK ASSESSMENT
15
APPENDIX
15.1
DISCUSSION GUIDE
15.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3
CUSTOMIZATION OPTIONS
15.4
RELATED REPORTS
15.5
AUTHOR DETAILS
Methodology
This study utilized both primary and secondary sources to analyze the healthcare analytical testing services market. Extensive secondary research was conducted, followed by primary research to validate findings with industry experts. Various methods were used to estimate the overall market size, including top-down and bottom-up approaches. Market segmentation and data triangulation were then applied to define different segments within the market. The research also explored influencing factors, key players, industry trends, competitive dynamics, and strategies of market participants.
Secondary Research
The secondary research process relies on various sources like directories, databases (e.g., Bloomberg Business, Factiva, D&B Hoovers), white papers, annual reports, company documents, investor presentations, and SEC filings. This research was essential for a detailed market analysis of healthcare analytical testing services, providing insights into key players and market segmentation trends. Additionally, it highlighted significant market and technology developments, leading to the creation of a database of industry leaders.
The market for healthcare analytical testing services is assessed using secondary data from various sources. This analysis reviews major companies' product portfolios and performance, providing insights into the industry's value chain, key players, and market segmentation from both market and technology perspectives.
Primary Research
In the primary research process for this report, various supply- and demand-side sources were interviewed to gather qualitative and quantitative data. Supply-side sources included industry experts like CEOs and key executives from prominent companies in healthcare analytical testing services. On the demand side, primary sources comprised OEMs, private testing organizations, and service providers. This research validated market segmentation, identified key players, and gathered insights on industry trends and dynamics.
Following market engineering, which involved calculations for statistics, breakdowns, and forecasting, we conducted extensive primary research to verify critical numbers. We identified market segmentation types, trends, and the competitive landscape while examining key dynamics such as drivers, restraints, opportunities, and challenges faced by major players.
In the comprehensive market engineering process, both top-down and bottom-up approaches were employed to estimate and forecast market segments. Extensive qualitative and quantitative analyses highlighted essential insights presented in the report.
A breakdown of the primary respondents is provided below:
Note 1: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were utilized to estimate and validate the healthcare analytical testing services market size and its segments. Revenue share analysis of leading players helped determine the global market size, with insights gathered from primary and secondary research. This included reviewing annual reports of top players and conducting interviews with key executives.
Healthcare Analytical Testing Services Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the global healthcare analytical testing services market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the market was validated using both top-down and bottom-up approaches.
Market Definition
Healthcare analytical testing services support pharmaceutical, biopharmaceutical, and medical device companies in ensuring product quality, safety, efficacy, and regulatory compliance across development and manufacturing. The market covers bioanalytical testing, physical characterization, method development & validation, raw material, batch-release, stability, microbial, environmental monitoring, genomic, and other analytical testing services. Growth is driven by increasing outsourcing, stringent regulatory requirements, rising clinical trials, growing R&D expenditure, and increasing development of biologics and biosimilars. Advanced analytical technologies and growing laboratory investments are further improving testing capabilities, efficiency, and support for complex therapies.
Key Stakeholders
- Healthcare Analytical Testing Service Providers
- Pharmaceutical & Biopharmaceutical Companies
- Biotechnology Companies
- Bioanalytical Testing Service Providers
- Environmental Testing Service Providers
- Contract Research Organizations (CROs)
- Medical Device Manufacturing Companies
- Academic Universities
- Research Institutes
- Research Laboratories
- Government Associations
- Cosmetic Companies
- Nutraceutical Companies
- Hospitals and Clinics
- Forensic Laboratories
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and forecast the healthcare analytical testing services market based on type, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global healthcare analytical testing services market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global healthcare analytical testing services market
- To analyze key growth opportunities in the global healthcare analytical testing services market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments and/or subsegments with respect to five major regions: North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, Thailand, Singapore, Indonesia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Africa)
- To profile the key players in the global healthcare analytical testing services market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global healthcare analytical testing services market, such as agreements, expansions, and product launches
Available customizations:
With the given market data, MarketsandMarkets offers customizations to meet your company’s needs. The following customization options are available for the present global healthcare analytical testing services market report:
Service Analysis
- Service matrix, which gives a detailed comparison of the service portfolios of the top ten companies
Company Information
- Detailed analysis and profiling of additional market players (up to 10)
Geographic Analysis
- Further breakdown of the Rest of Europe healthcare analytical testing services market into Russia, Belgium, Spain, Switzerland, Austria, Finland, Sweden, Poland, and Portugal
- Further breakdown of the Rest of Asia Pacific healthcare analytical testing services market into South Korea, Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries
- Further breakdown of the Rest of Latin America healthcare analytical testing services market into Argentina, Chile, Peru, and Colombia
Key Questions Addressed by the Report
What is the projected value of the global healthcare analytical testing services market during the forecast period?
The global healthcare analytical testing services market is projected to grow from USD 7.48 billion in 2025 to USD 12.48 billion by 2030, at a CAGR of 10.8% during the forecast period.
By type, which segment accounted for the largest market share in 2024?
Based on type, the bioanalytical testing services segment accounted for the largest share of the healthcare analytical testing services market in 2024. The time constraints and exorbitant costs of drug discovery being controlled through effective bioanalysis are key factors driving market growth.
What strategies are adopted by the leading players in the market?
The leading players in the market have opted for launches, collaborations, partnerships, agreements, and expansions as critical growth strategies to expand their presence in the global healthcare analytical testing services market.
What are the primary factors expected to drive the growth of the healthcare analytical testing services market?
The stringent regulatory guidelines and increasing outsourcing of analytical testing by pharmaceutical & medical device companies are the key factors driving market growth.
What are the specific challenges companies face in the healthcare analytical testing services market?
The presence and adoption of new techniques and technologies such as high-resolution accurate mass spectrometry (HRAM) instruments, morphologically directed Raman spectroscopy (MDRS), and fully validated laboratory information & management systems (LIMS) may challenge this market's growth.
Fact checked
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Healthcare Analytical Testing Services Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
- US Healthcare Analytical Testing Services Market
- Canada Healthcare Analytical Testing Services Market
- Germany Healthcare Analytical Testing Services Market
- UK Healthcare Analytical Testing Services Market
- France Healthcare Analytical Testing Services Market
- Italy Healthcare Analytical Testing Services Market
- Switzerland Healthcare Analytical Testing Services Market
- Spain Healthcare Analytical Testing Services Market
- China Healthcare Analytical Testing Services Market
- Japan Healthcare Analytical Testing Services Market
- India Healthcare Analytical Testing Services Market
- South Korea Healthcare Analytical Testing Services Market
- Australia Healthcare Analytical Testing Services Market
- Brazil Healthcare Analytical Testing Services Market
- Mexico Healthcare Analytical Testing Services Market
Growth opportunities and latent adjacency in Healthcare Analytical Testing Services Market
Aaron
Jun, 2026
After reviewing the Healthcare Analytical Testing Services Market report, I found the increasing outsourcing of complex testing requirements to specialized service providers to be a key trend, especially among smaller biotech firms lacking in-house capabilities..
Natalie
Jun, 2026
From a technical operations angle, the Healthcare Analytical Testing Services Market highlights how stringent regulatory expectations are driving demand for advanced analytical techniques to ensure product safety and consistency..
Jonathan
Jun, 2026
Looking at the strategic landscape, my takeaway from the Healthcare Analytical Testing Services Market is that companies offering integrated testing solutions across the drug development lifecycle are better positioned to capture long-term client relationships..